Ushida, Naoki; Nagai, Nobukazu; Adachi, Masaatsu; Nishikawa, Toshio published the article 《Concise Stereocontrolled Synthesis of an α-Carbagalactose Segment of RCAI-56, a Candidate Anticancer Agent》. Keywords: organocatalyst RCAI56 glycolipid benzyloxybutadiene acrolein Diels Alder stereoselective preparation; benzyloxybutadiene acrolein Diels Alder stereoselective cyclitol preparation antitumor; cyclitol preparation antitumor carbagalactose NKT chlorobutene Diels Alder synthon.They researched the compound: (R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride( cas:323196-43-6 ).Recommanded Product: (R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:323196-43-6) here.
RCAI-56 is a synthetic glycolipid exhibiting a potent antitumor activity by stimulation of natural killer T cells. Tetra- O-benzyl-α-carbagalactose, an important synthetic segment of RCAI-56, was stereoselectively synthesized from 1,4-dichloro-2-butene in nine steps, including the key step of organo-catalytic asym. Diels-Alder reaction between acrolein and 1-benzyloxybutadiene.
In addition to the literature in the link below, there is a lot of literature about this compound((R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride)Recommanded Product: (R)-5-Benzyl-2,2,3-trimethylimidazolidin-4-one hydrochloride, illustrating the importance and wide applicability of this compound(323196-43-6).
Reference:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics